Nutreco invests in ViAqua to combat diseases in shrimp farming

ViAqua is developing the first orally administered treatment for shrimp that improves resistance to viral diseases, including White Spot Syndrome Virus (WSSV), and prevents viral epidemics.

July 5, 2018

Nutreco has announced that it has invested in Israeli startup ViAqua as part of its focus on combatting disease in the aquaculture industry. ViAqua is developing the first orally-administered treatment for shrimp that improves resistance to viral diseases, including White Spot Syndrome Virus (WSSV), and prevents viral epidemics. 

The solution offered by ViAqua, which was founded in 2014, uses a proprietary particle to disable viral infections. In the future, ViAqua intends to expand to include more species, like other shellfish such as lobster and crab, and small fish. 

Nutreco has taken a meaningful minority share that will conditionally grow over time. Other shareholders in the company include The Trendlines and the Technion – Israel Institute of Technology, both based in Israel. 

“Preventing and treating disease, particularly viral infections, is one of the biggest challenges facing the aquaculture industry today," stated Knut Nesse, Nutreco CEO. "In shrimp farming alone, diseases cause 10-20% losses. Working together with Viaqua, we will be able to offer targeted solutions to reduce and prevent disease.”

Viggo Halseth, Nutreco’s Chief Innovation Officer and head of Nutreco NuFrontiers – the company’s startup investment arm – added, “The solution that ViAqua has developed is a unique and highly innovative way of combatting disease in shrimp. This is a very relevant technology to handle a significant health challenge and has convincing proof-of-concept. ViAqua is exactly the kind of innovative and technological partner we want to be working with in future.” 

Nutreco’s aquaculture division Skretting will work directly with ViAqua to effectively deliver the solution to the market. 

“This investment fits well with our strategy to strengthen our activities in providing health solutions to farmers," stated Therese Log Bergjord, CEO of Skretting. "ViAqua’s knowledge of how to combat health challenges in shrimp coupled with our expertise on application through feed and our reach in shrimp markets around the world mean that together we can really begin to have an impact on aquaculture health.”

CEO and Co-Founder of ViAqua Shai Ufaz commented, “We are excited to have strategic investors of the caliber of Nutreco aboard and the strength of the joint agreement with Skretting. Nutreco and Skretting’s combined resources and rich knowledge of the aquafeed industry will provide ViAqua with an outstanding opportunity to develop technologies with the right fit for the market.”